USPH
US Physical Therapy Inc
$
86.930
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
87.470
Open
85.480
VWAP
86.70
Vol
179.86K
Mkt Cap
1.32B
Low
81.3222
Amount
15.59M
EV/EBITDA(TTM)
17.29
Total Shares
15.07M
EV
1.70B
EV/OCF(TTM)
23.74
P/S(TTM)
1.79
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 774 outpatient physical therapy clinics in 44 states. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre and post operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
193.98M
+15.44%
0.662
-4.12%
198.34M
+9.92%
0.693
+35.83%
196.68M
+7.01%
0.600
+25%
Estimates Revision
The market is revising Upward the revenue expectations for U.S. Physical Therapy, Inc. (USPH) for FY2025, with the revenue forecasts being adjusted by 1.64% over the past three months. During the same period, the stock price has changed by 23.55%.
Revenue Estimates for FY2025
Revise Upward
+1.64%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+5.49%
In Past 3 Month
Stock Price
Go Up
+23.55%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast USPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for USPH is 106.50 USD with a low forecast of 103.00 USD and a high forecast of 110.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 86.930
Low
103.00
Averages
106.50
High
110.00
Current: 86.930
Low
103.00
Averages
106.50
High
110.00
JPMorgan
Benjamin Rossi
Overweight
initiated
$110
2025-09-18
Reason
JPMorgan
Benjamin Rossi
Price Target
$110
2025-09-18
initiated
Overweight
Reason
JPMorgan analyst Benjamin Rossi assumed coverage of U.S. Physical Therapy with an Overweight rating and $110 price target. The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. The analyst believes U.S. Physical Therapy is well positioned to benefit from long-term demographic trends.
Barrington
analyst
Outperform
maintain
$98 -> $103
2025-08-08
Reason
Barrington
analyst
Price Target
$98 -> $103
2025-08-08
maintain
Outperform
Reason
Barrington raised the firm's price target on U.S. Physical Therapy to $103 from $98 and keeps an Outperform rating on the shares. Q2 revenue "exceeded our Street-high estimate" and adjusted EPS also came in "well above" the firm's expectation and consensus, notes the analyst, who raising the firm's 2025 and 2026 adjusted EBITDA estimates following the report.
JMP Securities
Constantine Davides
Buy
Reiterates
$113
2025-04-22
Reason
JMP Securities
Constantine Davides
Price Target
$113
2025-04-22
Reiterates
Buy
Reason
JP Morgan
Calvin Sternick
Buy
Maintains
$120 → $110
2025-03-19
Reason
JP Morgan
Calvin Sternick
Price Target
$120 → $110
2025-03-19
Maintains
Buy
Reason
JPMorgan lowered the firm's price target on U.S. Physical Therapy to $110 from $120 and keeps an Overweight rating on the shares. Following Q4 earnings, the firm is updating its estimates, noting that for 2025 it increased its revenue estimate to $747M while bringing down its adjusted EBITDA estimate to $91M. For 2026, the firm increased its revenue estimate to $794M while maintaining its adjusted EBITDA estimate at $101M, the analyst added.
Barrington Research
Michael Petusky
Buy
Maintains
$108 → $98
2025-02-28
Reason
Barrington Research
Michael Petusky
Price Target
$108 → $98
2025-02-28
Maintains
Buy
Reason
JMP Securities
Constantine Davides
Buy
Initiates
$113
2024-12-16
Reason
JMP Securities
Constantine Davides
Price Target
$113
2024-12-16
Initiates
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for US Physical Therapy Inc (USPH.N) is 31.09, compared to its 5-year average forward P/E of 35.03. For a more detailed relative valuation and DCF analysis to assess US Physical Therapy Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
35.03
Current PE
31.09
Overvalued PE
39.71
Undervalued PE
30.36
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
20.91
Current EV/EBITDA
18.45
Overvalued EV/EBITDA
23.42
Undervalued EV/EBITDA
18.39
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
2.56
Current PS
86.27
Overvalued PS
7.46
Undervalued PS
-2.35
Financials
Annual
Quarterly
FY2025Q2
YoY :
+18.04%
197.34M
Total Revenue
FY2025Q2
YoY :
+21.92%
24.70M
Operating Profit
FY2025Q2
YoY :
+51.30%
17.72M
Net Income after Tax
FY2025Q2
YoY :
+23.40%
0.58
EPS - Diluted
FY2025Q2
YoY :
+18.15%
31.46M
Free Cash Flow
FY2025Q2
YoY :
+2.17%
22.14
Gross Profit Margin - %
FY2025Q2
YoY :
-22.51%
8.26
FCF Margin - %
FY2025Q2
YoY :
+28.10%
8.98
Net Margin - %
FY2025Q2
YoY :
+32.13%
5.14
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
301.3K
USD
3
3-6
Months
311.3K
USD
4
6-9
Months
232.9K
USD
3
0-12
Months
49.7K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
8.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
2
16.0K
USD
Months
0-12
2
16.0K
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
301.3K
USD
3
3-6
Months
311.3K
USD
4
6-9
Months
232.9K
USD
3
0-12
Months
49.7K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
USPH News & Events
Events Timeline
2025-08-01 (ET)
2025-08-01
07:34:57
U.S. Physical Therapy acquires physical therapy practice, terms undisclosed
2025-05-28 (ET)
2025-05-28
16:14:08
U.S. Physical Therapy announces dual listing on NYSE Texas
2025-05-07 (ET)
2025-05-07
16:27:21
U.S. Physical Therapy reports Q1 operating EPS 48c, consensus 45c
Sign Up For More Events
Sign Up For More Events
News
9.5
10-22NewsfilterU.S. Physical Therapy, Inc. Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
6.5
10-17NASDAQ.COMUnexpected 12-Month Forecast for IJR by Analyst
6.5
10-11Yahoo FinanceInvestor Reactions to Operational Challenges and Declining Returns at U.S. Physical Therapy (USPH)
Sign Up For More News
People Also Watch
SILA
Sila Realty Trust Inc
23.530
USD
-0.72%
GEL
Genesis Energy LP
16.060
USD
-1.83%
AMC
AMC Entertainment Holdings Inc
2.580
USD
-0.39%
SGML
Sigma Lithium Corp
5.355
USD
-17.49%
PBI
Pitney Bowes Inc
9.830
USD
-0.51%
TPC
Tutor Perini Corp
68.210
USD
+1.26%
RBCAA
Republic Bancorp Inc
65.450
USD
-0.68%
SCS
Steelcase Inc
15.840
USD
-0.75%
BLBD
Blue Bird Corp
51.630
USD
+3.34%
FAQ
What is US Physical Therapy Inc (USPH) stock price today?
The current price of USPH is 86.93 USD — it has increased 0.77 % in the last trading day.
What is US Physical Therapy Inc (USPH)'s business?
What is the price predicton of USPH Stock?
What is US Physical Therapy Inc (USPH)'s revenue for the last quarter?
What is US Physical Therapy Inc (USPH)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for US Physical Therapy Inc (USPH)'s fundamentals?
How many employees does US Physical Therapy Inc (USPH). have?